HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU’s Cosmetic Microplastic Restriction Expected To Be ‘Very Wide-Ranging’ At Best

Executive Summary

Cosmetics Europe’s Director-General John Chave discusses next steps in the European Union’s proposed drive to ban manufactured microplastic in all cosmetic products. Industry continues to fight for something more proportionate, but it’s up against powerful forces in today’s European theater.

You may also be interested in...



EU Ban Looms On Cosmetic Microplastic: Time To Dig In On Biodegradable Plastic Terms?

Biodegradable plastic alternatives for use in cosmetic products were left unaddressed, and thus arguably unusable, under the US Microbead-Free Waters Act enacted in late 2015. European industry stakeholders now face the prospect of a far more extensive microplastic ban, and the viability of bioplastics to replace conventional, petroleum-based microplastics is an area in need of work.

Endocrine Disruptors, The European Green Deal And The Politicization Of EU Chemical Programs

John Chave, director-general at Cosmetics Europe, says the European Commission’s plan for targeted assessment of 28 potential endocrine-disruptors in cosmetics – despite its conclusion in late 2018 that the current cosmetics regulatory framework adequately addresses endocrine-disruptor concerns – is symptomatic of a broad trend taking hold in Europe.

Microplastic, Macro-Headache: European Cosmetics Industry Dismayed By Early Signs In Restriction Process

Initial committee debate as to whether ECHA’s proposed microplastic restriction meets regulatory threshold requirements for substances posing “unacceptable risk” was shorter-lived than industry advocates anticipated, following the contentious proposal’s issuance at the end of January. Cosmetics Europe head John Chave provides an update on the process and discusses next steps.

Related Content

Topics

UsernamePublicRestriction

Register

RS149629

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel